Plant homeodomain finger protein 2 as a novel IKAROS target in acute lymphoblastic leukemia.
暂无分享,去创建一个
Z. Ge | Baoan Chen | Qinyu Ge | Chunhua Song | Q. Han | S. Dovat | Jiaojiao Hu | Y. Gu | Jinlong Ma | Huihui Song | Justin Sloane | Goufeng Gao
[1] Chunhua Song,et al. Cellular signaling and epigenetic regulation of gene expression in leukemia , 2019, Advances in biological regulation.
[2] P. Jedlicka,et al. Biology and targeting of the Jumonji-domain histone demethylase family in childhood neoplasia: a preclinical overview , 2019, Expert opinion on therapeutic targets.
[3] L. Szekely,et al. Aberrant ARID5B expression and its association with Ikaros dysfunction in acute lymphoblastic leukemia , 2018, Oncogenesis.
[4] K. Moon,et al. Implication of PHF2 Expression in Clear Cell Renal Cell Carcinoma , 2017, Journal of pathology and translational medicine.
[5] Ji-Young Kim,et al. Regulatory role of G9a and LSD1 in the Transcription of Olfactory Receptors during Leukaemia Cell Differentiation , 2017, Scientific Reports.
[6] A. Ashworth,et al. Marked for death: targeting epigenetic changes in cancer , 2017, Nature Reviews Drug Discovery.
[7] C. Mullighan,et al. Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia. , 2017, Experimental hematology.
[8] R. Gale,et al. Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia , 2016, Scientific Reports.
[9] Y. Shang,et al. Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis. , 2016, The Journal of clinical investigation.
[10] Robert A. Weinberg,et al. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability , 2016, Science.
[11] S. Armstrong,et al. MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C. , 2016, The Journal of clinical investigation.
[12] Q. Li,et al. Epigenetic regulation of gene expression by Ikaros, HDAC1 and Casein Kinase II in leukemia , 2015, Leukemia.
[13] A. Davidoff,et al. Histone demethylases and their roles in cancer epigenetics. , 2016, Journal of medical oncology and therapeutics.
[14] H. Ouyang,et al. Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia* , 2015, The Journal of Biological Chemistry.
[15] Y. Kawasawa,et al. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia , 2015, Oncotarget.
[16] S. Armstrong,et al. JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors , 2015, Genes & development.
[17] G. Robertson,et al. Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia. , 2015, Blood.
[18] Z. Ge,et al. Characterization of LEF1 High Expression and Novel Mutations in Adult Acute Lymphoblastic Leukemia , 2015, PloS one.
[19] H. Ouyang,et al. Protein Phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros‐mediated repression of TdT in thymocytes and T‐cell leukemia , 2014, Pediatric blood & cancer.
[20] J. Ablain,et al. Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia , 2014, International journal of cancer.
[21] W. H. Kim,et al. PHF2 histone demethylase acts as a tumor suppressor in association with p53 in cancer , 2014, Oncogene.
[22] R. Jaenisch,et al. Contrasting roles for histone 3 lysine 27 demethylases in acute lymphoblastic leukemia , 2014, Nature.
[23] Kristian Helin,et al. Histone lysine demethylases as targets for anticancer therapy , 2013, Nature Reviews Drug Discovery.
[24] Yuuki Imai,et al. Epigenetic Regulation of Adipogenesis by PHF2 Histone Demethylase , 2013, Diabetes.
[25] N. Perrimon,et al. Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20. , 2012, Molecular cell.
[26] R. Pieters,et al. Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements , 2012, Haematologica.
[27] R. Juergens. Targeting epigenetic changes in non-small cell lung cancer , 2012 .
[28] S. Mukherjee,et al. Association of FANCC and PTCH1 with the Development of Early Dysplastic Lesions of the Head and Neck , 2012, Annals of Surgical Oncology.
[29] Amy K. Erbe,et al. Regulation of Ikaros function by casein kinase 2 and protein phosphatase 1. , 2011, World journal of biological chemistry.
[30] Clifford A. Meyer,et al. PKA-dependent regulation of the histone lysine demethylase complex PHF2–ARID5B , 2011, Nature Cell Biology.
[31] Kevin K Dobbin,et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. , 2010, Blood.
[32] Min Gyu Lee,et al. Recognition of Histone H3K4 Trimethylation by the Plant Homeodomain of PHF2 Modulates Histone Demethylation* , 2010, The Journal of Biological Chemistry.
[33] J. Downing,et al. Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. , 2010, Blood.
[34] K. Hung,et al. Ikaros Stability and Pericentromeric Localization Are Regulated by Protein Phosphatase 1* , 2009, Journal of Biological Chemistry.
[35] Satyabrata Sinha,et al. Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: Pathological significance in early- and late-onset breast carcinoma , 2008, Molecular Cancer.
[36] K. Helin,et al. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. , 2008, Genes & development.
[37] D. Campana,et al. Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. , 1985, Journal of immunology.